Myeloid growth factors in acute myeloid leukemia: Systematic review of randomized controlled trials

Annals of Hematology

Volumn 90, Issue 3, 2011, Pages 273-281

  Heuser, Michael ^a   Zapf, Antonia ^a   Morgan, Michael ^a   Krauter, Jürgen ^a   Ganser, Arnold ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AML; Febrile neutropenia; G CSF; GM CSF

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COCHRANE LIBRARY; DATA ANALYSIS; DISEASE FREE SURVIVAL; DRUG EFFICACY; EVENT FREE SURVIVAL; HUMAN; INFECTION; LENGTH OF STAY; LEUKEMIA REMISSION; MEDLINE; META ANALYSIS; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; COLONY-STIMULATING FACTORS; HUMANS; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE;

EID: 79951671916     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1069-z     Document Type: Article

References (38)

1. M Heuser A Ganser 2005 Colony-stimulating factors in the management of neutropenia and its complications Ann Hematol 84 11 697 708 10.1007/s00277-005- 1087-4 16047204 (Pubitemid 41447804)
2. GH Lyman NM Kuderer B Djulbegovic 2002 Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis Am J Med 112 5 406 411 1:CAS:528: DC%2BD38XitFWmurs%3D 10.1016/S0002-9343(02)01036-7 11904116 (Pubitemid 34246271)
3. L Sung PC Nathan B Lange J Beyene GR Buchanan 2004 Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials J Clin Oncol 22 16 3350 3356 1:CAS:528:DC%2BD2cXpsVGrsbc%3D 10.1200/JCO.2004.09.106 15310780 (Pubitemid 41103693)
4. Sasse EC, Sasse AD, Brandalise S, Clark OA, Richards S (2005) Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database Syst Rev (3):CD004139
5. B Wittman J Horan GH Lyman 2006 Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials Cancer Treat Rev 32 4 289 303 1:CAS:528: DC%2BD28Xltlemu74%3D 10.1016/j.ctrv.2006.03.002 16678350 (Pubitemid 44502006)
6. NM Kuderer DC Dale J Crawford GH Lyman 2007 Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review J Clin Oncol 25 21 3158 3167 1:CAS:528:DC%2BD2sXptlGrtL4%3D 10.1200/JCO.2006.08.8823 17634496 (Pubitemid 47218066)
7. Bohlius J, Herbst C, Reiser M, Schwarzer G, Engert A (2008) Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database Syst Rev (4):CD003189
8. T Berghmans M Paesmans JJ Lafitte, et al. 2002 Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis Support Care Cancer 10 3 181 188 1:STN:280:DC%2BD387nt1Cisg%3D%3D 10.1007/s00520-001-0312-5 11904782 (Pubitemid 36056292)
9. OA Clark GH Lyman AA Castro LG Clark B Djulbegovic 2005 Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials J Clin Oncol 23 18 4198 4214 1:CAS:528:DC%2BD2MXmt1els7k%3D 10.1200/JCO.2005.05.645 15961767 (Pubitemid 46211326)
10. T Buchner WE Berdel W Hiddemann 2004 Priming with granulocyte colony-stimulating factor-relation to high-dose cytarabine in acute myeloid leukemia N Engl J Med 350 21 2215 2216 10.1056/NEJM200405203502124 15152074 (Pubitemid 38659503)
11. JL Harousseau B Witz B Lioure, et al. 2000 Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques J Clin Oncol 18 4 780 787 1:CAS:528:DC%2BD3cXhs1akurY%3D 10673519 (Pubitemid 30106608)
12. TJ Smith J Khatcheressian GH Lyman, et al. 2006 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 19 3187 3205 1:CAS:528:DC%2BD28XnslKhsLo%3D 10.1200/JCO.2006.06.4451 16682719 (Pubitemid 46638957)
13. G Heil D Hoelzer MA Sanz, et al. 2006 Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia Leukemia 20 3 404 409 1:CAS:528:DC%2BD28Xhs1Kjur0%3D 10.1038/sj.leu.2404090 16424872 (Pubitemid 43291736)
14. R Zittoun S Suciu F Mandelli, et al. 1996 Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group J Clin Oncol 14 7 2150 2159 1:STN:280:DyaK283otlWgtQ%3D%3D 8683249 (Pubitemid 26230119)
15. B Lowenberg MA Boogaerts SM Daenen, et al. 1997 Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia J Clin Oncol 15 12 3496 3506 1:CAS:528:DyaK2sXotFSqsbk%3D 9396403 (Pubitemid 27527723)
16. S Amadori S Suciu U Jehn, et al. 2005 Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Blood 106 1 27 34 1:CAS:528:DC%2BD2MXlvVWjs74%3D 10.1182/blood-2004-09-3728 15761020 (Pubitemid 40967170)
17. K Usuki A Urabe T Masaoka, et al. 2002 Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study Br J Haematol 116 1 103 112 1:CAS:528: DC%2BD38XhvFGkt70%3D 10.1046/j.1365-2141.2002.03251.x 11841402 (Pubitemid 34122066)
18. K Wheatley AH Goldstone T Littlewood A Hunter AK Burnett 2009 Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party Br J Haematol 146 1 54 63 1:CAS:528:DC%2BD1MXptlWgsbY%3D 10.1111/j.1365-2141.2009.07710.x 19438472
19. JM Rowe JW Andersen JJ Mazza, et al. 1995 A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490) Blood 86 2 457 462 1:CAS:528:DyaK2MXmvVyhtLo%3D 7605984
20. H Nakajima Y Ikeda K Hirashima, et al. 1995 A randomized controlled study of rG.CSF in patients with neutropenia after induction therapy for acute myelogenous leukemia. (rG.CSF Clinical Study Group) Rinsho Ketsueki 36 6 597 605 1:STN:280:DyaK2MzntFWrsQ%3D%3D 7543955
21. A Takeshita R Ohno K Hirashima, et al. 1995 A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group) Rinsho Ketsueki 36 6 606 614 1:STN:280:DyaK2MzntFWrtg%3D%3D 7543956
22. G Heil D Hoelzer MA Sanz, et al. 1997 A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group Blood 90 12 4710 4718 1:CAS:528:DyaK2sXnvFWksLo%3D 9389686 (Pubitemid 28007183)
23. X Thomas E Raffoux S Botton, et al. 2007 Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group Leukemia 21 3 453 461 1:CAS:528:DC%2BD2sXhvFWksb4%3D 10.1038/sj.leu.2404521 17252021
24. EH Estey PF Thall S Pierce, et al. 1999 Randomized phase II study of fludarabine+cytosine arabinoside+idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome Blood 93 8 2478 2484 1:CAS:528:DyaK1MXisVGktro%3D 10194425 (Pubitemid 29181178)
25. Y Saito N Uchida S Tanaka, et al. 2010 Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML Nat Biotechnol 28 3 275 280 1:CAS:528:DC%2BC3cXitVWnsLk%3D 20160717
26. X Thomas E Raffoux A Renneville, et al. 2010 Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study Cancer 116 7 1725 1732 1:CAS:528:DC%2BC3cXkvFOns70%3D 10.1002/cncr.24943 20143449
27. RM Stone DT Berg SL George, et al. 1995 Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B N Engl J Med 332 25 1671 1677 1:STN:280:DyaK2M3otV2ktA%3D%3D 10.1056/NEJM199506223322503 7760868
28. H Dombret C Chastang P Fenaux, et al. 1995 A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group N Engl J Med 332 25 1678 1683 1:STN:280:DyaK2M3otV2ktQ%3D%3D 10.1056/ NEJM199506223322504 7539109
29. JE Godwin KJ Kopecky DR Head, et al. 1998 A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031) Blood 91 10 3607 3615 1:CAS:528:DyaK1cXjtFersrY%3D 9572995 (Pubitemid 28225726)
30. K Bradstock J Matthews G Young, et al. 2001 Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia Leukemia 15 9 1331 1338 1:CAS:528:DC%2BD3MXmvVGmuro%3D 10.1038/sj.leu.2402218 11516093 (Pubitemid 32785302)
31. G Heil L Chadid D Hoelzer, et al. 1995 GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML) Leukemia 9 1 3 9 1:STN:280:DyaK2M7kslCqtg%3D%3D 7845026
32. B Lowenberg S Suciu E Archimbaud, et al. 1997 Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group Blood 90 8 2952 2961 1:CAS:528:DyaK2sXms1Crtrs%3D 9376575
33. F Witz A Sadoun MC Perrin, et al. 1998 A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM) Blood 91 8 2722 2730 1:CAS:528:DyaK1cXisVWlt7c%3D 9531581 (Pubitemid 28227521)
34. R Hast E Hellstrom-Lindberg L Ohm, et al. 2003 No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease Leukemia 17 9 1827 1833 1:CAS:528:DC%2BD3sXntFCitbk%3D 10.1038/sj.leu.2403035 12970783 (Pubitemid 37185259)
35. B Lowenberg W van Putten M Theobald, et al. 2003 Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia N Engl J Med 349 8 743 752 10.1056/NEJMoa025406 12930926 (Pubitemid 37010778)
36. JM Rowe D Neuberg W Friedenberg, et al. 2004 A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group Blood 103 2 479 485 1:CAS:528:DC%2BD2cXmsFCjsw%3D%3D 10.1182/blood-2003-05-1686 14512295 (Pubitemid 38140076)
37. C Lofgren C Paul M Astrom, et al. 2004 Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial Br J Haematol 124 4 474 480 1:STN:280:DC%2BD2c%2Fps1Giuw%3D%3D 10.1111/j.1365-2141.2004.04805.x 14984497 (Pubitemid 38230592)
38. DW Milligan K Wheatley T Littlewood JI Craig AK Burnett 2006 Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial Blood 107 12 4614 4622 1:CAS:528:DC%2BD28XlvFCgsL4%3D 10.1182/blood-2005-10-4202 16484584 (Pubitemid 43882605)